D61.811 — Other drug-induced pancytopenia
Is D61.811 billable?
Yes — D61.811 is billable for FY2027. D61.811 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D61.811 may be submitted for encounters from October 1, 2026 through September 30, 2027.
D61.811 at a glance
| Code | D61.811 |
|---|---|
| Description | Other drug-induced pancytopenia |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D61.811 group to?
D61.811 sits in MDC 16 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 808Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with MCCmedical
- 809Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CCmedical
- 810Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCCmedical
As a secondary diagnosis, D61.811 is a major complication or comorbidity (MCC), which can move a stay into a higher-paying DRG.
How is D61.811 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to D61.811. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Pancytopenia › drug-induced NEC (acquired)
Excludes2 — not included here
The conditions below are not part of D61.811, but a patient may have both at the same time. When documentation supports it, D61.811 and the excluded code may both be reported.
- aplastic anemia due to drugs (D61.1)
Excludes1 — never code together — inherited from D61.81
The conditions below can never be reported together with D61.811 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- pancytopenia (due to) (with) aplastic anemia (D61.9)
- pancytopenia (due to) (with) bone marrow infiltration (D61.82)
- pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
- pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
- pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
- pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
- pancytopenia (due to) (with) myeloproliferative disease (D47.1)
Excludes2 — not included here — inherited from Chapter 3
The conditions below are not part of D61.811, but a patient may have both at the same time. When documentation supports it, D61.811 and the excluded code may both be reported.
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Excludes2 — not included here — inherited from D61
The conditions below are not part of D61.811, but a patient may have both at the same time. When documentation supports it, D61.811 and the excluded code may both be reported.
- neutropenia (D70.-)
Excludes2 — not included here — inherited from D61.81
The conditions below are not part of D61.811, but a patient may have both at the same time. When documentation supports it, D61.811 and the excluded code may both be reported.
- pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
How long has D61.811 existed?
D61.811 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.